In conclusion, our study revealed that TROAP could promote malignant phenotype of glioma cells in vitro, at least in part, activating Wnt/β‐Catenin signaling pathway, thus proving the role of TROAP and underlying molecular mechanism of TROAP in gliomagenesis for the first time. The gene discussed is TROAP; the disease is glioma.